Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Frequently asked questions
What sector does Abeona Therapeutics Inc (ABEO) operate in?
Abeona Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Abeona Therapeutics Inc (ABEO) current stock price?
As of the latest data, Abeona Therapeutics Inc stock price is $4.31, with a previous close of $4.40. Abeona Therapeutics Inc lost -$0.09 in the last trading session, representing a -2.05% loss.
What is Abeona Therapeutics Inc (ABEO) current market capitalization?
Abeona Therapeutics Inc market cap is approximately 246.46 million.
What is Abeona Therapeutics Inc (ABEO) Earnings Per Share (EPS)?
The trailing EPS is -$1.21, and the forward EPS is -$0.04.
What is Abeona Therapeutics Inc (ABEO) EBITDA?
Abeona Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -18.80 million.
Does Abeona Therapeutics Inc (ABEO) pay dividends?
No. Abeona Therapeutics Inc does not pay a dividend.
How did Abeona Therapeutics Inc (ABEO) perform in its most recent earnings report?
In the last report (June 30, 2026), Abeona Therapeutics Inc posted an EPS surprise of -52.17% and a revenue surprise of -6.41%.
When is Abeona Therapeutics Inc (ABEO) next earnings report?
Abeona Therapeutics Inc is expected to release its next earnings report on September 30, 2026.
What is Abeona Therapeutics Inc (ABEO) beta (volatility) score?
Abeona Therapeutics Inc has a beta of 1.324, suggesting it is more volatile than the market.
